Top Wall Street analysts favor these 3 stocks for their growth potential

Analysts highlight three favored stocks after strong company reports and guidance: Credo Technology reported a 272% revenue surge in Q2 FY26, prompting Bank of America’s Vivek Arya to raise his price target to $240 (from $165) and cite a potential $10bn TAM and $10–$11 EPS at a 45% net margin under aggressive share assumptions; TipRanks’ AI analyst PT is $194. MongoDB beat Q3 FY26 expectations with Atlas revenue up ~30%, 2,600 new customers, and a 750-basis-point operating-margin beat, leading Stifel’s Brad Reback to raise his PT to $450 (from $375) and argue for sustained >20% Atlas growth. Walmart produced healthy Q3 FY26 results driven by e-commerce and membership growth, with Tigress’ Ivan Feinseth lifting his PT to $130 (from $125) while noting technology- and AI-driven efficiency and higher-margin initiatives such as retail media.

Analysis

Market structure: Hyperscaler-led AEC adoption (Credo) and cloud consumption (MongoDB Atlas) concentrate revenue with a handful of platform suppliers—winners are system-level SerDes/optical players (CRDO, NVDA ecosystem partners) and scale-native cloud software (MDB); losers are incumbents lacking differentiated system IP (pressure on MRVL/ALAB). Expect pricing power to rise for suppliers with design wins; if Credo secures 4→5 hyperscaler customers it can command premium ASPs and margin expansion (management projects mid-single-digit QoQ growth into FY26/27). Cross-asset: renewed risk-on into AI names likely lifts equities and pushes real yields up 10–30bp; small-cap AI names will see elevated IV (useful for options), while safer retail cashflows (WMT) could attract bond-like flows compressing credit spreads.

Risk assessment: Tail risks include a hyperscaler design reversal (single-customer exposure), aggressive price competition from Marvell driving CRDO AEC ASPs down >20%, or a macro slowdown that reduces cloud consumption by >15% YoY. Timeline: expect headline volatility in days around earnings/revenue beats; positioning and multi-year TAM claims play out over 12–36 months. Hidden dependency: CRDO’s path to $5bn sales assumes ~50% share—this is binary and correlates heavily to 1–2 hyperscaler program wins. Catalysts: quarterly Atlas consumption prints, hyperscaler procurement cycles (next 2–8 quarters), and Walmart’s retail-media ad rev growth cadence.

Key Decisions for Investors

• Establish a tactical 1–2% long position in CRDO (small-cap growth) now; size to risk budget and set a hard stop at -30% and trim half on a +50% rally or on failure to sustain mid-single-digit QoQ sales growth over next two quarters.
• Initiate a 2–3% net exposure to MDB via a 12–18 month call spread: buy 25% ITM LEAP call and sell a 50% OTM call to cap cost; target ~30–40% upside if Atlas growth stays >20% YoY; exit if Atlas revenue growth falls below 15% YoY on a trailing-4-quarter basis.
• Overweight WMT to 3–4% of portfolio (from neutral) for defensive, AI-driven retail media exposure; accumulate on dips >5% or weakness that pushes forward P/E below 22x; consider selling 3–6 month covered calls at +10% OTM to harvest yield until 1H 2026 results.
• Implement a relative-value pair: long CRDO vs short MRVL (1:1 notional, smaller size ~1% each) to express potential share shift; close pair if MRVL outperforms CRDO by >20% in 60 days or if CRDO confirms 3+ hyperscaler revenue contributors.
• Monitor three specific triggers in next 90 days before increasing allocations: (1) CRDO: confirmation of 5th hyperscaler revenue >5% of sales; (2) MDB: Atlas consumption growth staying >20% YoY; (3) WMT: retail-media margin expansion reported quarter-over-quarter. Increase positions only if triggers met.